Kaste SC, Chesney RW, Hudson MM, Lustig RH, Rose SR, Carbone LD: Bone mineral density during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health
Documented benefits include improved insulin sensitivity in type 2 diabetes (20), reduced inflammatory cytokines and short-term mortality in sepsis (21), and ameliorated cardiac fibrosis in experimental heart failure models (22)
Well, were here to tell you that a new class of weight loss medications called GLP-1 agonists are earning this lofty description
Great for people managing blood pressure, blood sugar or overall health goals
Small molecule oral GLP-1 receptor agonists are currently in development, and we introduce how these chemicals have addressed the challenge posed by interactions with the large extracellular ligand binding domain of the GLP-1 receptor